As of 2024, the global Antisynthetase Syndrome Market was valued at USD 235.56 million. Moving into 2025, the market is benefiting from a wave of new diagnostic protocols and the off-label use of advanced biologics. The market is projected to grow to USD 382.59 million by 2032, exhibiting a Compound Annual Growth Rate (CAGR) of 6.25%. While the market remains smaller than broader a... https://livepositively.com/unlocking-value-pricing-regulatory-landscape-and-future-forecast-for-the-ocular-bromfenac-market-2025-2032/